advisorsecurities master

MNOVMedicinova, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key
18667
Ticker
MNOV
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2006-12-07
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
MNOV

Detail

Enriched 2026-08-14 20:47

Market cap
$65,464,257.18
Shares outstanding (class)
49,221,246
Shares outstanding (weighted)
49,221,246
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
6
Location
LA JOLLA, CA
Description

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data